Auxly Cannabis Group Stock Forecast, Price & News

Auxly Cannabis Group (OTCMKTS:CBWTF) Frequently Asked Questions

Is Auxly Cannabis Group a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Auxly Cannabis Group in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Auxly Cannabis Group stock.
View analyst ratings for Auxly Cannabis Group or view top-rated stocks.

How has Auxly Cannabis Group's stock been impacted by COVID-19?

Auxly Cannabis Group's stock was trading at $0.2830 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CBWTF stock has decreased by 57.2% and is now trading at $0.1210.
View which stocks have been most impacted by COVID-19.

How were Auxly Cannabis Group's earnings last quarter?

Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) issued its earnings results on Monday, November, 15th. The company reported ($0.02) earnings per share for the quarter. The business earned $19.45 million during the quarter. Auxly Cannabis Group had a negative trailing twelve-month return on equity of 24.92% and a negative net margin of 55.54%.
View Auxly Cannabis Group's earnings history.

What price target have analysts set for CBWTF?

3 equities research analysts have issued 12 month target prices for Auxly Cannabis Group's shares. Their forecasts range from $0.60 to $0.65. On average, they anticipate Auxly Cannabis Group's share price to reach $0.63 in the next twelve months. This suggests a possible upside of 416.5% from the stock's current price.
View analysts' price targets for Auxly Cannabis Group or view top-rated stocks among Wall Street analysts.

Who are Auxly Cannabis Group's key executives?

Auxly Cannabis Group's management team includes the following people:

• Hugo M. Alves, Chief Executive Officer & Director
• Michael Lickver, President
• Alan Cooke, Senior Vice President-Operations
• Brian Schmitt, Chief Financial Officer
• Christina Woollard, Principal Scientist

Who are some of Auxly Cannabis Group's key competitors?

Some companies that are related to Auxly Cannabis Group include Starpharma (SPHRY), Luna Innovations (LUNA), Bioqual (BIOQ), Inhibitor Therapeutics (INTI), ProMIS Neurosciences (ARFXF), AIkido Pharma (AIKI), AIkido Pharma (AIKI), iSpecimen (ISPC), Eloxx Pharmaceuticals (ELOX), HedgePath Pharmaceuticals (HPPI), Vitality Biopharma (VBIO), U.S. Stem Cell (USRM), Protalex (PRTX), DNAPrint Genomics (DNAG) and Affinity Energy and Health (ALGXY).
View all of CBWTF's competitors.

What is Auxly Cannabis Group's stock symbol?

Auxly Cannabis Group trades on the OTCMKTS under the ticker symbol "CBWTF."

How do I buy shares of Auxly Cannabis Group?

Shares of CBWTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Auxly Cannabis Group's stock price today?

One share of CBWTF stock can currently be purchased for approximately $0.12.

How much money does Auxly Cannabis Group make?

Auxly Cannabis Group has a market capitalization of $102.94 million and generates $37.92 million in revenue each year. The company earns $-63.77 million in net income (profit) each year or ($0.05) on an earnings per share basis.

How many employees does Auxly Cannabis Group have?

Auxly Cannabis Group employs 431 workers across the globe.

What is Auxly Cannabis Group's official website?

The official website for Auxly Cannabis Group is www.auxly.com.

Where are Auxly Cannabis Group's headquarters?

Auxly Cannabis Group is headquartered at 777 Richmond St W Unit 002, Toronto A6, M6J 0C2.

How can I contact Auxly Cannabis Group?

Auxly Cannabis Group's mailing address is 777 Richmond St W Unit 002, Toronto A6, M6J 0C2. The company can be reached via phone at (647) 812-0121, via email at [email protected], or via fax at 1 647 812 0120.